Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): A systematic review and meta-analysis of observational cohort studies.

Published in: International journal of clinical practice (2020)

Pooled results of EHDs' studies assessing GLP-1 RAs effects favoured GLP-1 RAs for all-cause mortality and MACE while were neutral for HHF. Results should be interpreted cautiously because of studies' substantial heterogeneity and limitations of observational research.

Keyphrases

wild type
heart failure
case control
cross sectional
cardiovascular events
single cell
risk factors
left ventricular
coronary artery disease
clinical trial
type diabetes
study protocol